Comparative antidotal efficacy of activated charcoal tablets, capsules and suspension in healthy volunteers. 1990

H P Remmert, and M Olling, and W Slob, and W F van der Giesen, and A van Dijk, and A G Rauws
National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.

The efficacy of several formulations of activated charcoal (AC) was compared by measuring the intestinal absorption of a solution of 1 g paracetamol administered 2 min before administration of 5 g AC as suspension (200 ml), tablets (40 of 125 mg) or capsules (25 of 200 mg). The suspension medium without AC was used as the control treatment. Based on the results of a pilot experiment, an 8 subject panel was used in a two 4 x 4 Latin square design. All treatments with AC resulted in a statistically significant decrease in paracetamol absorption compared to the control treatment. The suspension was considerably and significantly more effective than the tablets or capsules. Treatment with tablets was slightly but significantly more effective than capsules. The intake of large numbers of tablets and capsules was difficult. In the hospital AC suspensions are available. For first aid elsewhere, at home, at the working place or in the general practitioner's surgery a preservable and easily redispersible AC formulation would be preferable to the present solid forms.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D002606 Charcoal An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant & Hackh's Chemical Dictionary, 5th ed) Activated Charcoal,Actidose,Actidose-Aqua,Adsorba,Carbomix,Charbon,CharcoAid,CharcoCaps,Charcodote,Formocarbine,Insta-Char,Kohle-Compretten,Kohle-Hevert,Kohle-Pulvis,Kohle-Tabletten Boxo-Pharm,Liqui-Char,Norit,Ultracarbon,Charcoal, Activated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000082 Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage. Acetamidophenol,Hydroxyacetanilide,Paracetamol,APAP,Acamol,Acephen,Acetaco,Acetominophen,Algotropyl,Anacin-3,Datril,N-(4-Hydroxyphenyl)acetanilide,N-Acetyl-p-aminophenol,Panadol,Tylenol,p-Acetamidophenol,p-Hydroxyacetanilide,Anacin 3,Anacin3
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000931 Antidotes Agents counteracting or neutralizing the action of POISONS. Antidote,Theriacs
D013535 Suspensions Colloids with liquid continuous phase and solid dispersed phase; the term is used loosely also for solid-in-gas (AEROSOLS) and other colloidal systems; water-insoluble drugs may be given as suspensions. Suspension
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

H P Remmert, and M Olling, and W Slob, and W F van der Giesen, and A van Dijk, and A G Rauws
January 1974, Clinical toxicology,
H P Remmert, and M Olling, and W Slob, and W F van der Giesen, and A van Dijk, and A G Rauws
January 1970, Arhiv za higijenu rada i toksikologiju,
H P Remmert, and M Olling, and W Slob, and W F van der Giesen, and A van Dijk, and A G Rauws
July 1986, Human toxicology,
H P Remmert, and M Olling, and W Slob, and W F van der Giesen, and A van Dijk, and A G Rauws
June 1985, British journal of clinical pharmacology,
H P Remmert, and M Olling, and W Slob, and W F van der Giesen, and A van Dijk, and A G Rauws
April 2007, Clinical therapeutics,
H P Remmert, and M Olling, and W Slob, and W F van der Giesen, and A van Dijk, and A G Rauws
November 1984, British journal of clinical pharmacology,
H P Remmert, and M Olling, and W Slob, and W F van der Giesen, and A van Dijk, and A G Rauws
November 1969, Journal of pharmaceutical sciences,
H P Remmert, and M Olling, and W Slob, and W F van der Giesen, and A van Dijk, and A G Rauws
September 1976, American journal of hospital pharmacy,
H P Remmert, and M Olling, and W Slob, and W F van der Giesen, and A van Dijk, and A G Rauws
September 1973, Toxicology and applied pharmacology,
H P Remmert, and M Olling, and W Slob, and W F van der Giesen, and A van Dijk, and A G Rauws
January 1976, Clinical toxicology,
Copied contents to your clipboard!